GI & Endoscopy

The University of Minnesota in Minneapolis launched a new clinical trial that will use CRISPR genetic engineering to treat metastatic gastrointestinal solid tumor cancer, according to an Oct. 12 press release.

Takeda has entered into a $1.04 billion licensing agreement with Arrowhead Pharmaceuticals around its phase 2 therapy ARO-AAT, which was designed to treat alpha-1 antitrypsin-associated liver disease.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of Oct. 5-9:

Independent gastroenterology practice Charleston (S.C.) GI opened an endoscopy center in Summerville, S.C., according to local media outlet Live 5 News.

Nearly 90 percent of U.S. gastroenterologists are open to leveraging artificial intelligence to improve colonoscopies, according to a study published in Endoscopy International Open.

Here are 10 updates from gastroenterology companies and practices from the past week:

Bradenton-based Florida Digestive Health Specialists recently opened a new location in Brandon, Fla., the Osprey Observer reports.

Exact Sciences and Pfizer will extend and amend an agreement to promote Exact's non-invasive stool and DNA colorectal cancer screening test Cologuard, Exact announced Oct. 7.

Rockford, Ill.-based Mercyhealth's Javon Bea Hospital in Rockton, Ill., opened the Rockton Campus Endoscopy Center Oct. 5, local news affiliate WIFR reports.

Following the FDA's labeling change, Miami-based Gastro Health now offers patients access to CapsoCam Plus treatments at home.